Clever Leaves Holdings Inc (CLVR)
1.75
+0.21
(+13.60%)
USD |
NASDAQ |
May 02, 15:17
Clever Leaves Holdings Research and Development Expense (Quarterly): 0.233M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.233M |
| September 30, 2023 | 0.292M |
| June 30, 2023 | 0.403M |
| March 31, 2023 | 0.212M |
| December 31, 2022 | 0.605M |
| September 30, 2022 | 0.343M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.359M |
| March 31, 2022 | 0.412M |
| December 31, 2021 | 0.509M |
| September 30, 2021 | 0.454M |
| June 30, 2021 | 0.305M |
| March 31, 2021 | 0.278M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.212M
Minimum
Mar 2023
0.605M
Maximum
Dec 2022
0.3671M
Average
0.351M
Median
Research and Development Expense (Quarterly) Benchmarks
| Tilray Brands Inc | 0.106M |
| Flora Growth Corp | 0.025M |
| Acasti Pharma Inc | 1.443M |
| Aurinia Pharmaceuticals Inc | 10.23M |
| Edesa Biotech Inc | 0.7045M |